Company

Karyopharm Therapeutics ($KPTI)

  • Biotech

Overview

Develops and investigates oral nuclear export inhibitor cancer therapies for patients with cancer, especially in disease areas with high unmet need for treatment options.

Part of the Research Triangle ecosystem